Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medmonk
AddedFeb 17, 2024
UpdatedJul 7, 2026
Medmonk

Medmonk

Seed

Medmonk: Tech platform aiding pharmacists to secure medication funding for patients in need.

HQ
Milpitas, CA, US
Founded
2012
Accelerator
Y Combinator logoY CombinatorW12
Overview
Compare
Fundraising
Employees
Website

Medmonk is a technology platform dedicated to combating medication non-adherence by enabling pharmacists to secure financial assistance for patients unable to afford their medications. The company partners with pharmaceutical companies, pharmacies, physicians, and health plans to improve health outcomes by ensuring access to chronic therapies.

Medmonk's impact is significant in promoting medication adherence and improving patient care. By facilitating collaboration among key healthcare stakeholders, the platform helps reduce financial barriers to essential treatments, benefiting patients and insurers alike.

Medmonk - Similar Companies

MedMe Health logo

MedMe Health

medmehealth.com

Medsense Health logo

Medsense Health

medsense.health

Medsbyme logo

Medsbyme

Medacheck logo

Medacheck

medacheck.com

Medisafe logo

Medisafe

medisafe.com

AdhereHealth logo

AdhereHealth

adherehealth.com

InpharmD logo

InpharmD

inpharmd.com

Concordance Health Solutions logo

Concordance Health Solutions

RobinHealth logo

RobinHealth

Remedial Health logo

Remedial Health

remedial.health

MediPocket logo

MediPocket

ScriptAssist Pharmacy logo

ScriptAssist Pharmacy

scriptassistrx.com

Monitor My Meds logo

Monitor My Meds

monitormymeds.com

Medvantx logo

Medvantx

medvantx.com

AdhereTech logo

AdhereTech

adheretech.com

Medmonk - Quick Facts

Who are Medmonk's competitors?

Companies similar to Medmonk include MedMe Health, Medsense Health, Medsbyme and Medacheck.

When was Medmonk founded?

Medmonk was founded in 2012.

Where is Medmonk's headquarters located?

Medmonk's headquarters is located in Milpitas, CA, US.

When was Medmonk's last funding round?

Medmonk's most recent funding round was for $10M (USD) in October 2016.

How much has Medmonk raised to-date?

As of Oct 10, 2016, Medmonk has raised a total of $10M (USD).

How many employees does Medmonk have?

Medmonk has 8 employees as of Feb 4, 2024.

Medmonk - Classification

NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 19 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 541700Scientific Research and Development Services
  • 456110Pharmacies and Drug Retailers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research